Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI San Diego Facility Lease — Property and equipment impairment

Similar metrics at other companies

ProPetro Holding Corp. logo
PUMPHydraulic Fracturing — Property and equipment impairment expense
$0
Enterprise Products Partners logo
EPDNgl Pipelines And Services — Total impairment charges for property, plant and equipment
$3.5M-50.0%
Enterprise Products Partners logo
EPDPetrochemical And Refined Products Services — Total impairment charges for property, plant and equipment
$4M+6.7%
Enterprise Products Partners logo
EPDOnshore Crude Oil Pipelines And Services — Total impairment charges for property, plant and equipment
$1M
Enterprise Products Partners logo
EPDOnshore Natural Gas Pipelines And Services — Total impairment charges for property, plant and equipment
$2.75M+57.1%
Arq, Inc. logo
ARQCorbin Impairment Charge — Property, plant and equipment, net
$8.59M

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TangibleAssetImpairmentCharges.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 4:06 PM EST
Fiscal year
FY2025
Accession
0001823239-26-000011

(1) During the fourth quarter of 2025, the Company vacated certain of its facilities in San Diego, California and recorded impairment of long-lived assets totaling $8.3 million ($4.8 million for operating lease right-of-use assets and $3.5 million for property and equipment) within restructuring on the consolidated statements of operations. This reflects the excess of the long-lived assets’ carrying values over their respective fair values, which were determined based on estimated future discounted cash flows and are classified as Level 3 in the fair value hierarchy. As part of the facility reductions, the Company also recorded inventory write-offs of $1.4 million within cost of revenue on the consolidated statements of operations. The Company recorded additional asset impairments totaling $4.9 million ($0.3

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s san diego facility lease — property and equipment impairment?
Maravai LifeSciences Holdings, Inc. (MRVI) reported san diego facility lease — property and equipment impairment of $3.5M in Q4 2025.
What does san diego facility lease — property and equipment impairment mean?
Captures the write-down of tangible property and equipment located at the San Diego facility when the carrying amount is no longer recoverable. This serves as an indicator of asset obsolescence or a strategic shift away from the manufacturing or research capabilities housed at this site.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s san diego facility lease — property and equipment impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude